The invention relates to neuroprotection and to medicaments for use
therein. Neuroprotection is induced by activation of neural growth
hormone receptors, primarily using medicaments comprising growth hormone,
growth hormone analogs or ligands which are functionally equivalent. Such
medicaments may also include one or more secondary neuroprotective
agents.